| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 1.357.911.173 $ | +333.331.445 $ | -11,7 % | 1.027.815.748 $ | +102.232.102 $ | +55,6 % | 939.575.089 $ | -97.008.428 $ | +12,0 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 1.237.039.745 $ | +382.317.218 $ | +44,7 % | 854.722.527 $ | +65.516.993 $ | +8,3 % | 789.205.534 $ | -117.810.095 $ | -13,0 % |
| ADC Therapeutics SA | ADCT | 55.303.560 $ | -7.363.364 $ | -11,8 % | 62.666.924 $ | +20.680.085 $ | +49,3 % | 41.986.839 $ | +19.896.748 $ | +90,1 % |
| LivaNova PLC | LIVN | 7.263.863 $ | -41.281.869 $ | -85,0 % | 48.545.732 $ | +6.484.852 $ | +15,4 % | 42.060.880 $ | +2.225.500 $ | +5,6 % |
| Absci Corp | ABSI | 28.804.073 $ | +3.713.992 $ | +14,8 % | 25.090.081 $ | +3.879.059 $ | +18,3 % | 21.211.022 $ | +495.199 $ | +2,4 % |
| FATE THERAPEUTICS INC | FATE | 12.648.957 $ | -3.570.955 $ | -22,0 % | 16.219.912 $ | +1.802.212 $ | +12,5 % | 14.417.700 $ | +4.246.785 $ | +41,8 % |
| Silence Therapeutics plc | SLN | 13.161.844 $ | +1.926.651 $ | +17,1 % | 11.235.193 $ | -1.320.514 $ | -10,5 % | 12.555.707 $ | +6.309.556 $ | +101,0 % |
| BOSTON SCIENTIFIC CORP | BSX | 9.162.180 $ | -10.336.209 $ | -53,0 % | ||||||
| ALX ONCOLOGY HOLDINGS INC | ALXO | 3.689.131 $ | -2.410.228 $ | -39,5 % | 6.099.359 $ | +4.691.566 $ | +333,3 % | 1.407.793 $ | -860.447 $ | -37,9 % |
| Penumbra Inc | PEN | 4.829.263 $ | -1.279.184 $ | -20,9 % | ||||||
| Merck & Co., Inc. | MRK | 3.236.020 $ | +497.849 $ | +18,2 % | 2.738.171 $ | +103.719 $ | +3,9 % | |||
| 1.357.911.173 $ | +333.331.445 $ | -11,7 % | 1.027.815.748 $ | +102.232.102 $ | +55,6 % | 939.575.089 $ | -97.008.428 $ | +12,0 % | ||